Around-the-clock support for specialty conditions is not just nice to have, it’s necessary. The Accredo Therapeutic Resource Center® (TRC) model is always ready to offer essential support and guidance for those taking life-changing and life-saving specialty medications to treat complex conditions. And these TRCs are available for all Cigna customers who receive specialty medications through Accredo® , Cigna's specialty pharmacy.
Access to the TRCs is standard, at no additional cost to clients or customers.
There are 15 TRCs, each focused on a specific condition – examples include asthma, cancer, human immunodeficiency virus (HIV), and multiple sclerosis. Each is equipped with a team of specialty-trained clinicians. They bring a wealth of knowledge that’s concentrated on each condition – helping customers and providers through the prior authorization process and advising on topics like medication administration, adherence and side-effect management.
TRCs work closely with customers to discover and overcome challenges.
The TRCs maintain open lines of communication. Team members are ready to answer the phone 24 hours a day, seven days a week. Each interaction reflects discretion and respect for the customer’s privacy. However, the availability and considerate support offered by the TRC clinicians is not the only thing that makes them so valuable. It is their drive to anticipate customer needs and help conquer adherence challenges – that might otherwise lead to hospitalizations or costly waste.
The HIV TRC exemplifies just how customers can benefit from condition-specific guidance – 90% adherence is standard for customers using this TRC.1
Adherence is key to treatment and prevention for customers on an HIV medication regimen. And that’s where the HIV TRC focuses. The first way we do this is by promoting generic therapies to keep costs low. Another way is by supporting a simplified single-tablet regimen, when indicated by the prior authorization process.
The HIV TRC also assists customers at high risk for HIV.
Customers determined to be at high risk for HIV infection may take a pre-exposure prophylaxis (PrEP) medication to help prevent it. The HIV TRC strives to understand and overcome the many adherence challenges patients taking a PrEP drug may face. They’re affected by factors like stigma, low risk perception, medication side effects, ineffective or inaccurate education about adherence, and the logistics of daily life.4
TRCs successfully connect customers to available financial resources.
Costs related to treating a complex chronic condition are an unavoidable reality. However, the TRC teams understand that a customer’s focus should remain on their health, rather than worrying about expenses. Customers worries may include unpaid bills, how they’ll manage time away from work during recovery from surgery, or how they’ll be able to pay for and remain adherent to all their prescribed medications.
TRC financial support has resulted in $6.3B in specialty pharmacy program savings, including $2B+ in therapy management cost avoidance – of benefit to both clients and customers.3
Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and details of coverage, review your plan documents or contact a Cigna representative.
All Cigna products and service are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, (CHLIC), Evernorth Care Solutions, Inc., Evernorth Behavioral Health, Inc., Cigna Health Management, Inc., Evernorth, Accredo Health Group, Inc., Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express Scripts Strategic Development, Inc. This newsletter is not intended for residents of New Mexico.
© 2022 Cigna. All rights reserved